Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
15.4%
% of EDOC's 39 holdings also in GNOM
15.0%
% of GNOM's 40 holdings also in EDOC
Overlap by Weight
Sector Drift (EDOC minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in EDOC |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
QIAGEN NV | 4.2% | 4.2% | 4.2% |
|
VERACYTE INC | 4.2% | 5.1% | 4.2% |
|
AGILENT TECHNOLOGIES INC | 4.1% | 4.1% | 4.1% |
|
ILLUMINA INC | 3.8% | 3.8% | 3.8% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.7% | 1.0% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
EDOC Overweight Relative to GNOM
 |
PRO MEDICUS LIMITED | 5.2% |
|
DOXIMITY, INC. CLASS A | 4.9% |
|
HIMS & HERS HEALTH, INC. CLASS A | 4.7% |
|
MASIMO CORPORATION | 4.6% |
|
INSULET CORP | 4.5% |
|
DEXCOM INC | 4.2% |
|
LABCORP HOLDINGS | 4.1% |
|
IRHYTHM TECHNOLOGIES, INC. | 4.0% |
|
RESMED INC | 3.9% |
|
QUEST DIAGNOSTICS | 3.8% |
EDOC Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -8.4% |
|
NATERA INC | -5.8% |
 |
BIONTECH SE SPONSORED ADR | -4.4% |
|
BIO-TECHNE CORPORATION | -4.2% |
|
BIOMARIN PHARMACEUTICAL INC | -3.8% |
|
SAREPTA THERAPEUTICS INC | -3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.7% |
|
BEAM THERAPEUTICS, INC. | -3.5% |
|
CRISPR THERAPEUTICS AG | -3.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |